3.1 0.01 (0.32%) | 01-10 10:41 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 35.98 | 1-year : | 36.76 |
Resists | First : | 30.8 | Second : | 31.47 |
Pivot price | 30.76 | |||
Supports | First : | 29.71 | Second : | 24.72 |
MAs | MA(5) : | 30.33 | MA(20) : | 30.75 |
MA(100) : | 30.92 | MA(250) : | 0 | |
MACD | MACD : | -0.2 | Signal : | -0.1 |
%K %D | K(14,3) : | 0 | D(3) : | 0 |
RSI | RSI(14): 44.1 | |||
52-week | High : | 32.02 | Low : | 27.86 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TGN ] has closed above bottom band by 27.4%. Bollinger Bands are 27.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 30.41 - 30.56 | 30.56 - 30.68 |
Low: | 29.91 - 30.12 | 30.12 - 30.29 |
Close: | 30.05 - 30.36 | 30.36 - 30.61 |
RetinalGeniX Technologies, Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders. Its products include the RetinalGeniX Imaging System, a diabetic non-mydriatic mass retinal imaging and screening device; and RetinalCam, a real-time in-home retinal monitoring, imaging, and physician alert system. The company was incorporated in 2017 and is headquartered in Petaluma, California. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Thu, 22 Feb 2024
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy - Yahoo Finance
Tue, 26 Dec 2023
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its ... - GlobeNewswire
Thu, 21 Dec 2023
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company's Medical Advisory Board - Yahoo Finance
Thu, 09 Nov 2023
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For ... - GlobeNewswire
Wed, 08 Nov 2023
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug ... - Yahoo Finance
Wed, 07 Jun 2023
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
OTC
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |